A New Tool To Assess Sarcoidosis Severity
Yasmine Wasfi(Pulmonary and Allergy Associates), Lisa A. Maier(National Jewish Health), Marc A. Judson(Cleveland Clinic), Yoshikazu Inoue(Fukujuji Hospital), Jan C. Grutters(University Medical Center Utrecht), James R. Murphy(University of Liverpool), Cecile S. Rose(Colorado School of Public Health), Lori Silveira(University of Colorado Denver)
Cited by 79
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k